PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsImpetigo
MeSH D007169 - impetigo
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D013290:Streptococcal infections
174 Companies
81 Drugs
$
Success rate
D013207:Staphylococcal skin infections
24 Companies
10 Drugs
$
Success rate
D007169: 
Impetigo
32 Companies
6 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaMupirocin Mupirocin  2003-11-07   
PadagisMupirocin Centany  2002-12-04   
Mupirocin Mupirocin  2003-11-07   
Taro PharmaceuticalMupirocin Mupirocin  2005-09-23   
Glenmark PharmaceuticalsMupirocin Mupirocin  2011-06-08   
AlmirallRetapamulin Altabax 2024-08-30 2007-04-12   
GSKRetapamulin Altargo  2007-05-24   
Mupirocin Bactroban  1987-12-31   
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
100%
1/1
Phase 2
50%
1/2
Phase 3
100%
10/10
Approved: 7Overall Success rate: 50%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Cefadroxil
GSK
Mupirocin,
Retapamulin,
Cefuroxime axetil,
Fusidic acid,
Ademetionine,
Bevifimod
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use